Try our mobile app

Dealing in securities by executive directors, the group company secretary and directors of major subsidiaries

Published: 2022-09-13 16:45:30 ET
<<<  go to JSE:SPG company page
Super Group Limited
(Incorporated in the Republic of South Africa)
(Registration number: 1943/016107/06)
Share code: SPG
ISIN: ZAE000161832
LEI: 378900A8FDADE26AD654
Debt Company Code: BISGL
(“Super Group”)

DEALING IN SECURITIES BY EXECUTIVE DIRECTORS, THE GROUP COMPANY SECRETARY
AND DIRECTORS OF MAJOR SUBSIDIARIES

  In compliance with paragraphs 3.63 to 3.66 and 6.42 to 6.44 of the JSE
  Limited Listings and Debt Listings Requirements (collectively, the
  “Listings Requirements”), shareholders and noteholders are advised that
  the executive directors have, in terms of the Share Appreciation Right
  Scheme 2005 (the “Scheme”), been granted share appreciation rights
  (“SARS”) to receive shares which grants have been accepted.

  Shareholder approval of the Scheme was obtained at the 2005 Annual
  General Meeting. All SARS have conditions attached and are subject to
  the rules of the Scheme. The Remuneration Committee approved the grants
  and the required clearance in terms of the Listings Requirements was
  obtained.

  The Scheme supports the principle of aligning management and shareholder
  interests. Performance conditions governing the vesting of these SARS
  are intended to be stretching but achievable. The performance conditions
  are related to headline earnings per share increasing by 2% per annum
  above the Consumer Price Inflation Index over the three-year performance
  period ending June 2025. The grants are conditional upon the participant
  remaining employed during the performance period.

  The SARS granted to and accepted by the following Directors vest upon
  confirmation that the performance conditions have been fulfilled.

    Name of                Number of        Nature of         Total Deemed
    director                    SARS        interest              Value
    P Mountford 1)           400 000   Direct, beneficial   R11 140 000.00
    C Brown (1)              200 000   Direct, beneficial    R5 570 000.00
    J Mackay (2)             100 000   Direct, beneficial    R2 785 000.00
    P Smith (3)              200 000   Direct, beneficial    R5 570 000.00
    B Makubalo (3)           200 000   Direct, beneficial    R5 570 000.00
    J Matlakala(4)            40 000   Direct, beneficial    R1 114 000.00
    K Pandaram (4)            40 000   Direct, beneficial    R1 114 000.00
    H Makhoba (4)             40 000   Direct, beneficial   R1 114 000.00
    G Watson (5)             200 000   Direct, beneficial    R5 570 000.00
    Total                  1 420 000

   Date of acceptance      08 September 2022
   Nature of transaction   Off market grant and acceptance of SARS
   Class of securities     Ordinary shares
   Strike Price            R27.85
   Vesting date            Following approval by the Remuneration
                           Committee based on the audited results for the
                           financial year ending 30 June 2025

(1)P Mountford and C Brown are Executive Directors of Super Group
(2)J Mackay is the Group Company Secretary of Super Group
(3)P Smith and B Makubalo are Directors of Super Group Trading Proprietary
Limited, a major subsidiary of Super Group
(4)J Matlakala, H Makhoba and K Pandaram are directors of Super Group
Holdings Proprietary Limited, a major subsidiary of Super Group
(5)G Watson is a Director of Alan Ford UK Limited, a major subsidiary of
Super Group



Sandton
13 September 2022

Equity Sponsor: Investec Bank Limited

Debt Sponsor: Rand Merchant Bank (a division of FirstRand Bank Limited)